Frontiers in Psychology
March 4, 2022
Agnieszka D. Sekula, Luke Downey, Prashanth Puspanathan
27 citations
Psychedelic-assisted psychotherapy (PP) shows promise for treating PTSD, anxiety, addiction, and depression, relying heavily on participant mindset and therapeutic environment. Virtual reality (VR) may enhance PP by aiding relaxation, reducing anxiety, promoting mindfulness, inducing altered states of consciousness, and evoking mystical experiences. However, VR's role remains speculative due to a lack of empirical evidence on combined use. Potential disadvantages include sensory overstimulation, cyber-sickness, and triggering traumatic memories. A balanced, evidence-based approach is needed for design and implementation across treatment phases.
Frontiers in Psychiatry
November 4, 2021
M.l. Williams, Diana Korevaar, Renee Harvey et al.
23 citations
After a 40-year research hiatus due to sociopolitical issues, psychedelic-assisted therapies are being reinvestigated for mental illness. Clinicians and researchers in Australia identified five categories of challenge to moving these therapies from clinical trials to community practice: inherent risks, poor clinical practice, inadequate infrastructure, problematic perceptions, and divisive relationships. They propose strategies including public-sector support for research and training to establish best practices, funding for equitable access, and a multidisciplinary advisory body to guide policy. While framed in Australia, the challenges and strategies may apply elsewhere.
Psychoactives
March 25, 2024
Agnieszka D. Sekula, Prashanth Puspanathan, Luke A. Downey et al.
1 citation
A review of three interventions that produce altered states of consciousness—psychedelic-assisted psychotherapy, Transcendental Meditation, and hypnotherapy—finds that the first two are linked to significant reductions in substance misuse and improvements in emotional, cognitive, and social functioning, motivation, self-identity, and meaning. Hypnotherapy, despite wider acceptance, shows mixed and minimal results for substance misuse treatment. The review notes common phenomenological, psychological, and neurobiological features among the interventions, suggesting possible convergent mechanisms, but also highlights mixed findings and methodological issues. Key research gaps and promising future directions are outlined.